Results 21 to 30 of about 47,605 (207)

Quantitative Proteomics to study Carbapenem Resistance in Acinetobacter baumannii

Frontiers in Microbiology, 2014
Acinetobacter baumannii is an opportunistic pathogen causing pneumonia, respiratory infections and urinary tract infections. The prevalence of this lethal pathogen increases gradually in the clinical setup where it can grow on artificial surfaces ...
Vishvanath eTiwari, Monalisa eTiwari
doaj   +1 more source

Discovery and Biosynthesis of the Novel Glycotetrapeptide Antibiotic Biffamycin A

Angewandte Chemie, EarlyView.
Genetic de‐regulation of a silent biosynthetic pathway allowed isolation and characterisation of a novel glycopeptide antibiotic named biffamycin A, which harbours unprecedented 5‐chloro‐4‐methoxy tryptophan and 3R‐hydroxy(α‐D‐mannoysl)‐D‐lysine moieties and is bioactive against MRSA and VRSA.
Michael W. Brigham, Edward S. Hems, Daniel C. L. Van, Justin E. Clarke, Sergey Nepogodiev, Julius S. P. Adamson, Christian Bassi, Michael E. Webb, Glyn R. Hemsworth, Orde Q. Munro, Barrie Wilkinson, Ryan F. Seipke   +11 more
wiley   +2 more sources

Advances in BODIPY Derivatives for Antibacterial Phototherapy

Angewandte Chemie, EarlyView.
This review systematically summarizes the design strategies and structure‐activity relationships of BODIPY‐based antibacterial phototherapy, covering molecular engineering of small‐molecule photosensitizers and nanoplatforms, bacterial targeting and carrier design, and discussing the challenges and future perspectives associated with clinical ...
Li Lv, Heejeong Kim, Hongchen Zhai, Hanqi Ren, Silu Wang, Cong Sun, Yafu Wang, Hosoowi Lee, Juyoung Yoon, Hua Zhang   +9 more
wiley   +2 more sources

Establishment and preliminary application of a rapid pathogen-specific phenotypic antibiotic susceptibility test for Acinetobacter baumannii

Di-san junyi daxue xuebao, 2021
Objective To establish a rapid phenotypic antibiotic susceptibility testing of Acinetobacter baumannii based on surfactant-propidium monoazide (PMAxx)-qPCR reaction system.
LUO Dan, LI Yuliang, WENG Bangbi, WANG Qian   +3 more
doaj   +1 more source

Ribotyping of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex [PDF]

Journal of Clinical Microbiology, 1992
The Acinetobacter calcoaceticus-Acinetobacter baumannii complex consists of four genotypically distinct but phenotypically very similar bacterial species or DNA groups: A. calcoaceticus (DNA group 1), A. baumannii (DNA group 2), unnamed DNA group 3 (P. J. M. Bouvet and P. A. D. Grimont, Int. J. Syst. Bacteriol.
openaire   +2 more sources

Structure and Evolution of Acinetobacter baumannii Plasmids [PDF]

Frontiers in Microbiology, 2020
Acinetobacter baumannii is an emergent bacterial pathogen that provokes many types of infections in hospitals around the world. The genome of this organism consists of a chromosome and plasmids. These plasmids vary over a wide size range and many of them have been linked to the acquisition of antibiotic-resistance genes.
Abraham D. Salgado-Camargo, Semiramis Castro-Jaimes, Rosa-Maria Gutierrez-Rios, Luis F. Lozano, Luis Altamirano-Pacheco, Jesús Silva-Sanchez, Ángeles Pérez-Oseguera, Patricia Volkow, Santiago Castillo-Ramírez, Miguel A. Cevallos   +9 more
openaire   +3 more sources

Acinetobacter infections: A growing threat in the hospital

Journal of Marine Medical Society, 2013
Acinetobacter baumannii is a Gram Negative coccobacilli implicated in causation of wide spectrum of nosocomial infections. Multidrug resistant Acinetobacter (MDR Acinetobacter) is emerging as an important cause of hospital acquired infections like ...
Ruby Chattopadhyay, Naveen Chawla, Ramesh Rao, Yamuna Jaikishan, Kainaz Sidhwa   +4 more
doaj   +1 more source

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

Advanced Materials, EarlyView.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa, Gracia Mendoza, Silvia Irusta, Manuel Arruebo   +3 more
wiley   +1 more source

Enhanced Infection Resistance and Regenerative Healing of Titanium Implants via Peptide‐Loaded Biodegradable Coatings

Advanced Materials Technologies, EarlyView.
This study presents a new biodegradable coating for titanium implants using a natural antimicrobial peptide, caerin 1.9. Applied via solvent casting, the coating offers sustained antibacterial protection and promotes healing. Tested on 3D‐printed porous titanium scaffolds, it effectively prevented infection—including against resistant bacteria—while ...
Hejie Li, Tianfang Wang, Nicolas Soro, Guoying Ni, Meg Allom, D. İpek Kurtböke, Xiaosong Liu, Damon Kent   +7 more
wiley   +1 more source

Extended-Spectrum Cephalosporinase in Acinetobacter baumannii [PDF]

Antimicrobial Agents and Chemotherapy, 2010
ABSTRACT An AmpC-type β-lactamase conferring high-level resistance to expanded-spectrum cephalosporins and monobactams was characterized from an Acinetobacter baumannii clinical isolate. This class C β-lactamase (named ADC-33) possessed a Pro210Arg substitution together with a duplication of an Ala residue
Rodriguez-Martinez, J.-M., Nordmann, P., Ronco, E., Poirel, L.   +3 more
openaire   +2 more sources